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INTRODUCTION 45
Leishmaniasis, a vector-borne disease, is transmitted by female phlebotomine sandflies. 46
This neglected tropical disease (NTD) is caused by hemoflagellate intracellular parasites of the 47 genus, Leishmania. (1, 2) Regarding a report by the World Health Organization, 2017, 48 leishmaniasis is the third most important vector borne disease and second leading cause of death 49 after malaria, (3) estimated at 700,000 to 1 million new cases and 20,000 to 30,000 deaths occur 50 annually. (1) Leishmaniasis is endemic in 97 countries of Asia, Africa and Latin America putting 51 5 continents with 350 million people at risk (1) 52
The clinical presentation of this disease depends on the interplay between the infected 53
Leishmania species and host immune responses. Hence, the clinical manifestation can be divided 54 in three major forms: cutaneous leishmaniasis (CL), mucocutaneous leishmaniasis (ML) and 55 visceral leishmaniasis (VL). Of these three, VL is the most severe form of this disease entailing a 56 mortality rate of almost 100% when left untreated. VL is mainly caused by two Leishmania 57 species, i.e., L. donovani and L. infantum, which are endemic in many regions of the world. Up 58 to now, VL has been reported in 35 countries and approximately 90% of the prevalence has been 59 reported in five countries, i.e., India, Bangladesh, Nepal, Brazil and Sudan.(4) 60
In Thailand, VL cases have been sporadically reported both in immunocompetent and 61 immunocompromized patients since the first autochthonous VL case was reported in 1999. 62
Molecular analyses have revealed that most VL cases reported in Thailand were caused by two 63 novel Leishmania species, that is, L. martiniquensis (MON-229, WHO code: 64 opportunistic disease among patients with HIV. Leishmaniasis has also been reported among 69 patients with other immunosuppressed states, such as transplantation, hematological 70 malignancies, rheumatological/connective tissue diseases and chronic inflammatory conditions. 71 (6) Leishmaniasis and HIV co-infection is one major complications and countries facing this 72 problem exhibit very high co-infection rates. (7, 8) 73 At present, many diagnostic approaches offering several techniques are available for VL 74 diagnosis such as parasitological methods including microscopic techniques, culture, 75 immunological methods for antigen and antibody based detections and molecular techniques 76 based on PCR methods. PCR methods have been proved to be one of the most effective 77 approaches for VL diagnosis due to its high sensitivity and specificity, rapidity and ability to 78 perform with a broad range of clinical specimens. The specificity of PCR can be adapted to 79 specific need by targeting conserved regions of a gene which have high copy numbers. 80
Moreover, the Leishmania species could be identified by sequencing PCR products, which could 81 benefit for the epidemiological study of the disease. However, the obvious drawbacks of this 82 method is mainly the need for specimens collected using an invasive methods such as, blood, 83 bone marrow or tissue biopsies requiring equipment and specifically trained personnel to perform. 84
(2, 9) The major advantages of using saliva rather than blood are easy access, noninvasive; 85 expertise not needed to collect the sample and inexpensive The purpose of collecting the fluid is 86 to detect the disease and follow up the affected individuals under treatment. (10) 87 coat, respectively. The result agreement between the nested-PCR-ITS1 using buffy coat and 185 saliva was 52%. Antibody detection for Leishmania by the DAT was 43.61% (133/305) and 186 result agreement between DAT and the nested-PCR-ITS1 using saliva was 46.5%. Agreement of 187 positive results among the three methods; the nested ITS1-PCR using saliva, the nested ITS1-188 PCR using buffy coat and DAT was 12.1% as shown in Table 1 The patients participating in this study were individuals with HIV/AIDS. The results of 275 this study showed that detectable viral load (>50 copies /mL) among patients with HIV/AIDS 276 could also elicit Leishmania antibody production revealing significantly differences of positive 277 DAT between those with a detectable viral load and nondetectable viral load. Related studies 278 have shown that positive antibody by DAT did not show concordance with positive Leishmania 279 DNA in the blood among patients with HIV/AIDS (14) . 280
Among 31 patients with HIV/AIDS presenting Leishmania infection, 29 asymptomatic 281 and 2 symptomatic VL cases had agreement with positive results using either two or three assays 282 (Table 4) were performed before and after VL treatment of which Leishmania DNA was eliminated and 292 disappeared after the treatment (24). As a result, they noted the usefulness of saliva to diagnose 293 specimens in both symptomatic and asymptomatic HIV/VL cases. Due to a small number of 294 cases in a related study, the sensitivity and specificity could not be calculated. The results of this 295 study revealed a lower sensitivity of the nested-PCR-ITS1 using saliva when compared with that This study also confirmed the presence of at least three species of Leishmania infections, 298 that is, L. siamensis, L. martiniquensis and L. donovani complex. Of these, L. siamensis was the 299 most predominant species, followed by L. martiniquensis which were identified among 300 asymptomatic VL patients with HIV/AIDS in Trang Province, southern Thailand. Moreover, 301 public health awareness for disease transmission should be of extreme concern because infected 302 persons could spread the disease in other areas. 303
In conclusion, this study demonstrated that the nested-PCR-ITS1 assays using saliva 304 samples should not be routinely used to early detect Leishmania infection especially, among 305 patients with asymptomatic VL due to its lower sensitivity compared with those using buffy coat. 306
At present, buffy coat appears to be a better specimen by far to diagnose asymptomatic and 307 symptomatic VL infection among individuals with HIV/AIDS. The use of both buffy coat and 308 saliva together as clinical specimens would increase the sensitivity of Leishmania detection. 309
Further improvement for saliva collection i.e., samples frozen from the point of collection before 310 DNA extraction or the use of a saliva collection kit to preserve the parasite DNA could offer an 311 opportunity to use saliva to diagnose VL. 312
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